Global Coronary Stents Market will be worth USD 6.1 billion by 2022 – New market reports by Data Bridge Market Research

Global Coronary Stents Market is expected to grow at 2.5% in the forecast period 2016 to 2022
Global Coronary Stents Market, By Type (Dual Therapy Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent (DES) (Paclitaxel, Limus-Based Drugs) (Slow-Absorption DES, Fast-Absorption DES), Bio-engineered Stent, Bare Metal Stent), By Material (Stainless Steel, Cobalt Alloy Metal, Gold, Tantalum, Nitinol, Polymers), Rate (Slow-Absorption Stents, Fast-Absorption Stents), By Application, By End-User, By Geography – Trends and Forecast to 2022

Global Coronary Stents Market is expected to reach USD 6.1 billion by 2022, from USD 5.1 billion in 2015 growing at a CAGR of 2.5% during the forecast period of 2016 to 2022.

Global Coronary Stents Market is segmented based on product types, material, application, absorption rate, drug, end-user, distribution channel, and geography.

For Sample Report: http://databridgemarketresearch.com/reports/global-coronary-stents-market/

On the basis of type, the global coronary stents market is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug eluting stent (DES), bio-engineered stent, bare metal stent. The drug eluting stent market is segmented into biodegradable and non-biodegradable.

Based on material, the market is segmented into stainless steel, cobalt alloy metal, gold, tantalum, nitinol, and polymers. Polymer market is further segmented into silicone, bioerodible polymer, polyethylene and polyurethane.

Based on application, the market is segmented into coronary artery disease, and peripheral artery disease.

To read more about the scope and findings of this report visit: http://databridgemarketresearch.com/coronary-stents-market-poised-grow-2-5/

On the basis of absorption rate, the market is segmented into slow-absorption stents, and fast-absorption stents.

Based on end-user, the market is segmented into Hospitals, Cardiac Centers, Others.

Based on geography, the market report covers data for regions namely North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. The report also covers company share analysis for Global, U.S., Europe, Germany, Asia-Pacific, Middle East & Africa, North America and South America.

Global players operating in this market are players operating in this market are Abbott Vascular, SciTech, Boston Scientific Corporation, Medinol Ltd, iVascular SLU, Stentys SA, Elixir Medical Corporation, Inspire MD, Hexacath, Medtronic, Orbusneich, Andramed GmbH, Cordis Corporation, Endocor GmbH, Eurocor GmbH, Comed B.V., MicroPort Scientific Corporation, Degania Silicone Ltd., Amaranth Medical, Inc., Terumo Corporation, Meril Life Sciences Pvt. Ltd., Elixir Medical Corporation, InSitu Technologies Inc., Alvimedica, Biotronik SE & Co. KG, AMG International GmbH, Arthesys, Translumina GmbH, Lepu Medical, Accura, CeloNova BioSciences, Inc., Minvasys, Svelte Medical, B. Braun Melsungen AG and, Eucatech AG among other companies.     

To Browse Full Report and Pricing: http://databridgemarketresearch.com/reports/global-coronary-stents-market/

 

Table of Content:

1. INTRODUCTION

      1.1. OVERVIEW OF THE  CORONARY STENTS MARKET

 

      1.2. MARKET SEGMENTATION & COVERAGE

 

              1.2.1. CURRENCY AND PRICING

 

              1.2.2. LIMITATION

 

              1.2.3. STAKEHOLDERS

 

2. RESEARCH METHODOLOGY

     2.1. KEY TAKEAWAYS

 

     2.2. ARRIVING AT THE GLOBAL CORONARY STENTS MARKET

 

              2.2.1. MARKET CRACKDOWN APPROACH

 

              2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

 

              2.2.3. DATA TRIANGULATION

 

              2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

 

              2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

 

              2.2.6. EPIDEMIOLOGY DATA FORECASTING MODEL

 

     2.4. GLOBAL CORONARY STENTS MARKET: RESEARCH SNAPSHOT

 

     2.5. ASSUMPTIONS

 

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

     4.1. OVERVIEW

 

     4.2. GLOBAL CORONARY STENTS MARKET: KEY PRIMARY INSIGHTS

 

     4.3. MARKET OVERVIEW

 

              4.3.1. DRIVERS

 

               4.3.2. RESTRAINTS

 

              4.3.3. OPPURTUNITIES

 

              4.3.4. THREATS

 

     4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

 

5. CORONARY STENTS MARKET, EPIDEMIOLOGY STUDIES

     5.1. OVERVIEW

 

     5.2. TOTAL NUMBER OF PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURES PERFORMED; (2010 – 2025)

 

              5.2.1. NORTH AMERICA, BY COUNTRY

 

              5.2.2. EUROPE, BY COUNTRY

 

              5.2.3. ASIA-PACIFIC, BY COUNTRY

 

              5.2.4. REST OF THE WORLD, BY COUNTRY

 

              5.2.5. SOURCES BIBLIOGRAPHY

 

     5.3. PREVALENT POPULATION OF DIAGNOSED ATHEROSCLEROSIS: (2010 – 2025)                                                  

 

              5.3.1. NORTH AMERICA, BY COUNTRY

 

              5.3.2. EUROPE, BY COUNTRY

 

              5.3.3. ASIA-PACIFIC, BY COUNTRY

 

              5.3.4. REST OF THE WORLD, BY COUNTRY

 

              5.3.5. SOURCES BIBLIOGRAPHY

 

     5.4. PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURES PERFORMED: FEMORAL ACCESS VS RADIAL ACCESS; (2010 – 2025)

 

              5.4.1. NORTH AMERICA, BY COUNTRY

 

              5.4.2. EUROPE, BY COUNTRY

 

              5.4.3. ASIA-PACIFIC, BY COUNTRY

 

              5.4.4. REST OF THE WORLD, BY COUNTRY

 

              5.4.5. SOURCES BIBLIOGRAPHY

 

6. CORONARY STENTS MARKET,  BY COMPETITIVE MARKET ASSESMENT

     6.1. OVERVIEW

 

     6.2. STENT TYPE: TRADITIONAL STENT VS DRUG ELUTING STENT

 

     6.3. SURGERY TYPE: ANGIOPLASTY VS CABG

 

     6.4. SURGERY TYPE: PTCRA VS TRADITIONAL ANGIOPLASTY

 

     6.5. SURGERY TYPE: TRADITIONAL ANGIOPLASTY VS LASER ANGIOPLASTY

 

7. CORONARY STENTS MARKET,  BY PRODUCT TYPE

     7.1. OVERVIEW

 

     7.2. DUAL THERAPY STENT (2014 – 2022)

 

     7.3. BIORESORBABLE VASCULAR SCAFFOLD (2014 – 2022)

 

     7.4. DRUG ELUTING STENT (DES), BY FORMULATION (2014 – 2022)

 

              7.4.1. PACLITAXEL

 

              7.4.2. LIMUS-BASED DRUGS

 

     7.5. DRUG ELUTING STENT (DES), BY ABSORBANCE (2014 – 2022)

 

              7.5.1. SLOW-ABSORPTION DES

 

              7.5.2. FAST-ABSORPTION DES

 

     7.6. BIO-ENGINEERED STENT (2014 – 2022)

 

     7.7. BARE METAL STENT (2014 – 2022)

 

8. CORONARY STENTS MARKET,  BY APPLICATION

     8.1. OVERVIEW

 

     8.2. CORONARY ARTERY DISEASE (2014 – 2022)

 

     8.3. PERIPHERAL ARTERY DISEASE (2014 – 2022)

 

9. CORONARY STENTS MARKET,  BY END-USER

     9.1. OVERVIEW

 

     9.2. HOSPITALS (2014 – 2022)

 

     9.3. CARDIAC CLINICS (2014 – 2022)

 

     9.4. AMBULATORY CENTERS (2014 – 2022)

 

     9.5. OTHERS (2014 – 2022)

 

10. CORONARY STENTS MARKET, BY GEOGRAPHY

     10.1. COUNTRYWISE CORONARY STENTS MARKET, (2014 – 2022)                            

 

     (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY) (MARKET VALUE (USD MILLION))

 

              10.1.1. NORTH AMERICA

 

                          10.1.1.1.      U.S.

 

                          10.1.1.2.      CANADA

 

                          10.1.1.3.      MEXICO

 

              10.1.2. EUROPE

 

                          10.1.2.1.      GERMANY

 

                          10.1.2.2.      FRANCE

 

                          10.1.2.3.      U.K.

 

                          10.1.2.4.      ITALY

 

                          10.1.2.5.      SPAIN

 

                          10.1.2.6.      RUSSIA

 

                          10.1.2.7.      TURKEY

 

                          10.1.2.8.      BELGIUM

 

                          10.1.2.9.      NETHERLANDS

 

                          10.1.2.10.    SWITZERLAND

 

                          10.1.2.11.    REST OF EUROPE

 

              10.1.3. ASIA-PACIFIC (APAC)

 

                          10.1.3.1.      JAPAN

 

                          10.1.3.2.      CHINA

 

                          10.1.3.3.      SOUTH KOREA

 

                          10.1.3.4.      INDIA

 

                          10.1.3.5.      AUSTRALIA

 

                          10.1.3.6.      SINGAPORE

 

                          10.1.3.7.      THAILAND

 

                          10.1.3.8.      MALAYSIA

 

                          10.1.3.9.      INDONESIA

 

                          10.1.3.10.    PHILIPPINES

 

                          10.1.3.11.    REST OF APAC

 

              10.1.4. SOUTH AMERICA

 

                          10.1.4.1.    BRAZIL

 

                          10.1.4.2.    REST OF SOUTH AMERICA

 

              10.1.5. MIDDLE EAST AND AFRICA (MEA)

 

                          10.1.5.1.    SOUTH AFRICA

 

                          10.1.5.2.    SAUDI ARABIA

 

                          10.1.5.3.    UNITED ARAB EMIRATES (U.A.E)

 

                          10.1.5.4.    REST OF MEA

 

     10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

 

11. CORONARY STENTS MARKET: COMPETITIVE LANDSCAPE

     11.1. GLOBAL CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

 

     11.2. U.S. CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

 

     11.3. EUROPE CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

 

     11.4. ASIA-PACIFIC CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

 

     11.5. SOUTH AMERICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

 

     11.6. MERGERS & ACQUISITIONS

 

     11.7. NEW PRODUCT DEVELOPMENT & APPROVALS

 

     11.8. REGULATORY CHANGES

 

12. CORONARY STENTS MARKET, COMPANY PROFILES

     12.1. ABBOTT VASCULAR

 

              12.1.1. OVERVIEW

 

              12.1.2. SWOT ANALYSIS

 

              12.1.3. PRODUCT PORTFOLIO

 

              12.1.4. REVENUE ANALYSIS

 

              12.1.5. ANALYSTS VIEW

 

     12.2. SCITECH

 

              12.2.1. OVERVIEW

 

              12.2.2. SWOT ANALYSIS

 

              12.2.3. PRODUCT PORTFOLIO

 

              12.2.4. REVENUE ANALYSIS

 

              12.2.5. ANALYSTS VIEW

 

     12.3. BOSTON SCIENTIFIC CORPORATION

 

              12.3.1. OVERVIEW

 

              12.3.2. SWOT ANALYSIS

 

              12.3.3. PRODUCT PORTFOLIO

 

              12.3.4. REVENUE ANALYSIS

 

              12.3.5. ANALYST VIEW

 

     12.4. MEDINOL LTD

 

              12.4.1. OVERVIEW

 

              12.4.2. SWOT ANALYSIS

 

              12.4.3. PRODUCT PORTFOLIO

 

              12.4.4. REVENUE ANALYSIS

 

              12.4.5. ANALYSTS VIEW

 

     12.5. IVASCULAR SLU

 

              12.5.1. OVERVIEW

 

              12.5.2. SWOT ANALYSIS

 

              12.5.3. PRODUCT PORTFOLIO

 

              12.5.4. REVENUE ANALYSIS

 

              12.5.5. ANALYSTS VIEW

 

     12.6. STENTYS SA

 

              12.6.1. OVERVIEW

 

              12.6.2. SWOT ANALYSIS

 

              12.6.3. PRODUCT PORTFOLIO

 

              12.6.4. REVENUE ANALYSIS

 

              12.6.5. ANALYSTS VIEW

 

     12.7. ELIXIR MEDICAL CORPORATION

 

              12.7.1. OVERVIEW

 

              12.7.2. SWOT ANALYSIS

 

              12.7.3. PRODUCT PORTFOLIO

 

              12.7.4. REVENUE ANALYSIS

 

              12.7.5. ANALYSTS VIEW

 

     12.8. INSPIRE MD

 

              12.8.1. OVERVIEW

 

              12.8.2. SWOT ANALYSIS

 

              12.8.3. PRODUCT PORTFOLIO

 

              12.8.4. REVENUE ANALYSIS

 

              12.8.5. ANALYSTS VIEW

 

     12.9. HEXACATH

 

              12.9.1. OVERVIEW

 

              12.9.2. SWOT ANALYSIS

 

              12.9.3. PRODUCT PORTFOLIO

 

              12.9.4. REVENUE ANALYSIS

 

              12.9.5 . ANALYSTS VIEW

 

     12.10. MEDTRONIC

 

              12.10.1. OVERVIEW

 

              12.10.2. SWOT ANALYSIS

 

              12.10.3. PRODUCT PORTFOLIO

 

              12.10.4. REVENUE ANALYSIS

 

              12.10.5. ANALYSTS VIEW

 

     12.11. ORBUSNEICH

 

              12.11.1. OVERVIEW

 

              12.11.2. SWOT ANALYSIS

 

              12.11.3. PRODUCT PORTFOLIO

 

              12.11.4. REVENUE ANALYSIS

 

              12.11.5. ANALYSTS VIEW

 

     12.12. ANDRAMED GMBH

 

              12.12.1. OVERVIEW

 

              12.12.2. SWOT ANALYSIS

 

              12.12.3. PRODUCT PORTFOLIO

 

              12.12.4. REVENUE ANALYSIS

 

              12.12.5. ANALYSTS VIEW

 

     12.13. CORDIS CORPORATION

 

              12.13.1. OVERVIEW

 

              12.13.2. SWOT ANALYSIS

 

              12.13.3. PRODUCT PORTFOLIO

 

              12.13.4. REVENUE ANALYSIS

 

              12.13.5. ANALYSTS VIEW

 

     12.14. ENDOCOR GMBH

 

              12.14.1. OVERVIEW

 

              12.14.2. SWOT ANALYSIS

 

              12.14.3. PRODUCT PORTFOLIO

 

              12.14.4. REVENUE ANALYSIS

 

              12.14.5. ANALYSTS VIEW

 

     12.15. EUROCOR GMBH

 

              12.15.1. OVERVIEW

 

              12.15.2. SWOT ANALYSIS

 

              12.15.3. PRODUCT PORTFOLIO

 

              12.15.4. REVENUE ANALYSIS

 

              12.15.5. ANALYSTS VIEW

 

     12.16. COMED B.V.

 

              12.16.1. OVERVIEW

 

              12.16.2. SWOT ANALYSIS

 

              12.16.3. PRODUCT PORTFOLIO

 

              12.16.4. REVENUE ANALYSIS

 

              12.16.5. ANALYSTS VIEW

 

     12.17. MICROPORT SCIENTIFIC CORPORATION

 

              12.17.1. OVERVIEW

 

              12.17.2. SWOT ANALYSIS

 

              12.17.3. PRODUCT PORTFOLIO

 

              12.17.5. ANALYSTS VIEW

 

     12.18. DEGANIA SILICONE LTD.

 

              12.18.1. OVERVIEW

 

              12.18.2. SWOT ANALYSIS

 

              12.18.3. PRODUCT PORTFOLIO

 

              12.18.4. REVENUE ANALYSIS

 

              12.18.5. ANALYSTS VIEW

 

     12.19. TERUMO CORPORATION

 

              12.19.1. OVERVIEW

 

              12.19.2. SWOT ANALYSIS

 

              12.19.3. PRODUCT PORTFOLIO

 

              12.19.4. REVENUE ANALYSIS

 

              12.19.5. ANALYSTS VIEW

 

     12.20. MERIL LIFE SCIENCES PVT. LTD.

 

              12.20.1. OVERVIEW

 

              12.20.2. SWOT ANALYSIS

 

              12.20.3. PRODUCT PORTFOLIO

 

              12.20.4. REVENUE ANALYSIS

 

              12.20.5. ANALYSTS VIEW

 

     12.21. ALVIMEDICA

 

              12.21.1. OVERVIEW

 

              12.21.2. SWOT ANALYSIS

 

              12.21.3. PRODUCT PORTFOLIO

 

              12.21.4. REVENUE ANALYSIS

 

              12.21.5. ANALYSTS VIEW

 

     12.22. ELIXIR MEDICAL CORPORATION

 

              12.22.1. OVERVIEW

 

              12.22.2. SWOT ANALYSIS

 

              12.22.3. PRODUCT PORTFOLIO

 

              12.22.4. REVENUE ANALYSIS

 

              12.22.5. ANALYSTS VIEW

 

     12.23. INSITU TECHNOLOGIES INC.

 

              12.23.1. OVERVIEW

 

              12.23.2. SWOT ANALYSIS

 

              12.23.3. PRODUCT PORTFOLIO

 

              12.23.4. REVENUE ANALYSIS

 

              12.23.5. ANALYSTS VIEW

 

     12.24. BIOTRONIK SE & CO. KG

 

              12.24.1. OVERVIEW

 

              12.24.2. SWOT ANALYSIS

 

              12.24.3. PRODUCT PORTFOLIO

 

              12.24.4. REVENUE ANALYSIS

 

              12.24.5. ANALYSTS VIEW

 

     12.25. AMG INTERNATIONAL GMBH

 

              12.25.1. OVERVIEW

 

              12.25.2. SWOT ANALYSIS

 

              12.25.3. PRODUCT PORTFOLIO

 

              12.25.4. REVENUE ANALYSIS

 

              12.25.5. ANALYSTS VIEW

 

     12.26. ARTHESYS

 

              12.26.1. OVERVIEW

 

              12.26.2. SWOT ANALYSIS

 

              12.26.3. PRODUCT PORTFOLIO

 

              12.26.4. REVENUE ANALYSIS

 

              12.26.5. ANALYSTS VIEW

 

     12.27. TRANSLUMINA GMBH

 

              12.27.1. OVERVIEW

 

              12.27.2. SWOT ANALYSIS

 

              12.27.3. PRODUCT PORTFOLIO

 

              12.27.4. REVENUE ANALYSIS

 

              12.27.5. ANALYSTS VIEW

 

     12.28. LEPU MEDICAL

 

              12.28.1. OVERVIEW

 

              12.28.2. SWOT ANALYSIS

 

              12.28.3. PRODUCT PORTFOLIO

 

              12.28.4. REVENUE ANALYSIS

 

              12.28.5. ANALYSTS VIEW

 

     12.29. ACCURA

 

              12.29.1. OVERVIEW

 

              12.29.2. SWOT ANALYSIS

 

              12.29.3. PRODUCT PORTFOLIO

 

              12.29.4. REVENUE ANALYSIS

 

              12.29.5. ANALYSTS VIEW

 

     12.30. CELONOVA BIOSCIENCES, INC.

 

              12.30.1. OVERVIEW

 

              12.30.2. SWOT ANALYSIS

 

              12.30.3. PRODUCT PORTFOLIO

 

              12.30.4. REVENUE ANALYSIS

 

              12.30.5. ANALYSTS VIEW

 

     12.31. MINVASYS

 

              12.31.1. OVERVIEW

 

              12.31.2. SWOT ANALYSIS

 

              12.31.3. PRODUCT PORTFOLIO

 

               12.31.4. REVENUE ANALYSIS

 

              12.31.5. ANALYSTS VIEW

 

     12.32. SVELTE MEDICAL

 

              12.32.1. OVERVIEW

 

              12.32.2. SWOT ANALYSIS

 

              12.32.3. PRODUCT PORTFOLIO

 

              12.32.4. REVENUE ANALYSIS

 

              12.32.5. ANALYSTS VIEW

 

     12.33. B. BRAUN MELSUNGEN AG

 

              12.33.1. OVERVIEW

 

              12.33.2. SWOT ANALYSIS

 

              12.33.3. PRODUCT PORTFOLIO

 

              12.33.4. REVENUE ANALYSIS

 

              12.33.5. ANALYSTS VIEW

 

     12.34. EUCATECH AG

 

              12.34.1. OVERVIEW

 

              12.34.2. SWOT ANALYSIS

 

              12.34.3. PRODUCT PORTFOLIO

 

              12.34.4. REVENUE ANALYSIS

 

              12.34.5. ANALYSTS VIEW              

 

13. APPENDIX

14. ABOUT DATA BRIDGE MARKET RESEARCH

 

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Other Reports:

Global Absorbable and Non-Absorbable Sutures Market- Trends and Forecast to 2022

By Product Type (Automated Suturing Devices (Disposable, Reusable), Sutures (Absorbable (Natural, Synthetic (Vicryl, Monocryl, Polydioxanone, Polyglycolic)), Non-Absorbable (Nylon, Prolene, Stainless Steel))), By Surgery Type (Cardiovascular, Ortho

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-coronary-stents-market/